CompletedNCT05124782ePRATUpdated Sep 15, 2025

Virtual Management of Rheumatoid Arthritis

An observational study in Rheumatoid Arthritis, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2025-09-15.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Study type: Observational
Model: Cohort
Time perspective: Prospective
Enrollment: 70
Sex: All

Study summary

The purpose of this study is to optimize the care of patients with RA seen in virtual consultation.

Read the detailed description

This study will be organized in two consecutive steps:

A first descriptive step that will consist of a retrospective analysis of virtual consultation records of patients with RA during the pandemic and lockdown period in order to analyze on which criteria the patients were assessed and followed during this period.
The second step will consist in evaluating the interest of the systematic use in virtual consultation of a patient reported outcome (PRO), the RAID (Rheumatoid Arthritis Impact of Disease) questionnaire; and analyze how its results influence the rheumatologist decision-making.

Conditions studied

Rheumatoid Arthritis

Browse trials for

Arthritis, Rheumatoid 2,888

Keywords

Rheumatoid arthritis
Virtual consultation
Telemedicine
Patient reported outcome

In context

Arthritis, Rheumatoid

2,888 studies on the registry are indexed under Arthritis, Rheumatoid; 390 are open to participants now.

This study's enrollment of 70 is below the median of 176 across 824 observational studies indexed under Arthritis, Rheumatoid.

Browse Arthritis, Rheumatoid studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Probability sample

Study population

Patients with rheumatoid arthritis followed in a tertiary center (University Hospital Cochin)

Inclusion criteria

Patients with rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria
Follow-up in the rheumatology department of Cochin Hospital
Affiliated with a social security scheme
Non-opposition to participating in the study
Patients with a valid email address (registration to the virtual consultation system)

Exclusion criteria

Exclusion Criteria:

Opposition to participate to this research
Inability to understand or speak French
Patient under tutor or curator ship
patients under medical state help

Study design

Observational model: Cohort
Time perspective: Prospective
Enrollment: 70 participants (actual)
Patient registry: No

Groups and cohorts

Patients with rheumatoid arthritis
Patients seen in virtual consultation
Other: Rheumatoid Arthritis Impact of Disease questionnaire

Interventions

OtherRheumatoid Arthritis Impact of Disease questionnaire
Rheumatoid Arthritis Impact of Disease questionnaire

What researchers measure

Primary outcomes

Rate of face to face consultation, hospitalization and therapeutic modifications
The primary outcome will be the rate of face to face consultation, hospitalization and therapeutic modifications decided by the rheumatologist during the virtual consultation
Time frame: Inclusion

Study locations

1 site

Rheumatology Department, Cochin Hospital
Paris, IDF 75014, France

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Sep 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT05124782
Lead sponsor: Assistance Publique - Hôpitaux de Paris
Collaborators: URC-CIC Paris Descartes Necker Cochin
Responsible party: Sponsor
First posted: Nov 18, 2021
Start date: Nov 30, 2021
Primary completion: Nov 22, 2023
Completion: Nov 22, 2023
Last update: Sep 15, 2025

Study contacts

Jérôme AVOUAC, MD, PhD

principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Arthritis, Rheumatoid→

Other studies from this sponsor

Assistance Publique - Hôpitaux de Paris

Start the discussion